Lin Shih Yi, Wang Ya Yu, Sheu Wayne Huey-Herng
Division of Endocrinology and Metabolism, Taichung Veterans General Hospital, Institute of Clinical Medicine, School of Medicine, National Yang Ming University,Taiwan.
Clin Endocrinol (Oxf). 2002 Dec;57(6):805-11. doi: 10.1046/j.1365-2265.2002.01672.x.
Several reports have documented the involvement of hyerleptinaemia in malnutrition associated with liver cirrhosis. However, the mechanisms of elevated leptin levels remains unclear. Serum concentrations of tumour necrosis factor-alpha (TNF-alpha), and two soluble TNF receptors (sTNF-RI and sTNF-RII) are increased in patients with liver cirrhosis. In rodents, administration of TNF-alpha has been shown to stimulate plasma leptin concentration, suggesting that a cytokine-leptin link may mediate anorexia and weight loss during chronic inflammation. In this study, we investigate the potential interaction of the TNF-alpha system with leptin in the development of malnutrition in liver cirrhosis.
A total of 26 male patients with liver cirrhosis and 25 healthy people were recruited at an outpatient clinic at the Veterans General Hospital in Taiwan. Serum biochemistry and anthropometric measurement by bioelectrical impedance analysis were used to assess nutrition status, and immunoassay was used to determine serum leptin, TNF-alpha sTNF-RI and sTNF-RII concentrations.
In cirrhotic patients, the body fat mass (FM) and serum albumin levels were both lower than control subjects [15.8 (13.2-19.5) kg vs. 18.9 (16.2-20.1) kg; 35 (33-41) g/l vs. 43 (41-45) g/l, respectively; P < 0.05]. Serum TNF-alpha sTNF-RI and sTNF-RII were significantly elevated in cirrhotic patients compared to healthy controls [9.8 (7.2-13.5) ng/l vs. 4.3 (3.4-7.3) ng/l; 1682.1 (1344.8-2179.4) ng/l vs. 1319.6 (1037.7-1632.1) ng/l; 4462.2 (3748.5-5159.4) ng/l vs. 3559.8 (2506.9-3988.9 ng/l, respectively; P < 0.01] and correlated with disease severity (graded by Pugh-Child's scores). An inverse correlation was observed between circulating sTNF-RI and sTNF-RII to serum albumin levels (r =-0.42, r = -0.398; P < 0.05). The serum leptin levels in cirrhotic patients were significantly higher [6.0 (3.6-7.7) (g/l vs. 3.4 (2.9-4.3) (g/l; P < 0.01) and correlated with body FM (r = 0.52; P < 0.01]. Using a multiple linear regression analysis with leptin as dependent variable and FM and TNF-alpha, sTNF-R as independent variables, FM and serum sTNF-RI concentrations were found to predict independently the leptin levels in cirrhotic patients.
Our study demonstrated that serum levels of TNF-alpha, sTNF-RI, sTNF-RII and leptin were all elevated in cirrhotic patients. The severity of liver cirrhosis was an important factor for the activation of TNF-alpha system. The activated TNF-alpha system conjointly with hyperleptinaemia might mediate malnutrition in patients with liver cirrhosis.
多项报告记录了高瘦素血症与肝硬化相关营养不良的关系。然而,瘦素水平升高的机制仍不清楚。肝硬化患者血清肿瘤坏死因子-α(TNF-α)以及两种可溶性TNF受体(sTNF-RI和sTNF-RII)浓度升高。在啮齿动物中,已证明给予TNF-α可刺激血浆瘦素浓度,这表明细胞因子-瘦素联系可能介导慢性炎症期间的厌食和体重减轻。在本研究中,我们调查了TNF-α系统与瘦素在肝硬化营养不良发生过程中的潜在相互作用。
在台湾荣民总医院门诊招募了26名男性肝硬化患者和25名健康人。采用血清生化检查和生物电阻抗分析进行人体测量以评估营养状况,并用免疫测定法测定血清瘦素、TNF-α、sTNF-RI和sTNF-RII浓度。
肝硬化患者的体脂肪量(FM)和血清白蛋白水平均低于对照组[分别为15.8(13.2 - 19.5)kg对18.9(16.2 - 20.1)kg;35(33 - 41)g/L对43(41 - 45)g/L;P < 0.05]。与健康对照组相比,肝硬化患者血清TNF-α、sTNF-RI和sTNF-RII显著升高[分别为9.8(7.2 - 13.5)ng/L对4.3(3.4 - 7.3)ng/L;1682.1(1344.8 - 2179.4)ng/L对1319.6(1037.7 - 1632.1)ng/L;4462.2(3748.5 - 5159.4)ng/L对3559.8(2506.9 - 3988.9)ng/L,P < 0.01],且与疾病严重程度(根据Pugh-Child评分分级)相关。循环中的sTNF-RI和sTNF-RII与血清白蛋白水平呈负相关(r = -0.42,r = -0.398;P < 0.05)。肝硬化患者的血清瘦素水平显著更高[6.0(3.6 - 7.7)μg/L对3.4(2.9 - 4.3)μg/L;P < 0.01],且与体FM相关(r = 0.52;P < 0.01)。以瘦素为因变量,FM和TNF-α、sTNF-R为自变量进行多元线性回归分析,发现FM和血清sTNF-RI浓度可独立预测肝硬化患者的瘦素水平。
我们的研究表明,肝硬化患者血清TNF-α、sTNF-RI、sTNF-RII和瘦素水平均升高。肝硬化的严重程度是激活TNF-α系统的重要因素。激活的TNF-α系统与高瘦素血症共同作用可能介导肝硬化患者的营养不良。